Your Heart Races When You Stand. Here's the Biological Reason.

Your blood vessels need to relax and widen to allow blood to flow freely. Nitric oxide is the chemical that signals blood vessel walls to do exactly that. When you stand up, your arteries and veins should dilate slightly to accommodate the gravity-driven shift in blood volume. NOS3 is the enzyme that manufactures nitric oxide inside blood vessel cells. It’s working every moment to keep your vascular tone flexible and responsive.

The Glu298Asp variant in NOS3, carried by roughly 30 to 40 percent of people, reduces the amount of nitric oxide your blood vessels can produce. This isn’t a total shutdown. It’s a chronic under-production. Your blood vessels are constantly more constricted than they should be, and the dilation response to standing is blunted. That means when you shift position, your vessels can’t relax fast enough to prevent blood pooling in your legs.

You notice this as dizziness when you stand, a racing heart trying to compensate, and that feeling of not quite enough oxygen reaching your brain. The problem gets worse with heat, prolonged standing, or exercise, because your vessels are already at the edge of their dilation capacity and can’t adapt further.

Your body has a sophisticated system for controlling blood pressure moment by moment. The renin-angiotensin-aldosterone system is the master control. ACE is a key enzyme in that system: it converts angiotensin I, a relatively inactive precursor, into angiotensin II, a potent vasoconstrictor. In other words, ACE helps your blood vessels squeeze tighter when needed to maintain pressure. This is essential. Without it, your blood pressure would be dangerously low.

The I/D polymorphism in ACE determines how much enzyme your cells produce. People homozygous for the D allele, roughly 25 percent of people, produce significantly more ACE activity. That means your blood vessels are constantly receiving stronger signals to constrict, and your baseline blood pressure is higher. This is initially protective in POTS because it counteracts blood pooling. But it comes at a cost: your vessels lose flexibility. They’re in a state of chronic tension.

You experience this as elevated baseline heart rate, sometimes white-coat hypertension, and a sensation of your heart working harder than it should for normal activity. Over time, the constant vasoconstriction can lead to reduced blood flow to muscles and brain during exertion, compounding POTS symptoms.

MTHFR catalyzes a critical step in the methylation cycle, a biochemical process that underpins dozens of body functions. One of those functions is the synthesis of neurotransmitters, particularly those that regulate your autonomic nervous system: serotonin, dopamine, and norepinephrine. Another is the regulation of homocysteine, an amino acid that, when elevated, damages blood vessel walls and increases thrombosis risk. MTHFR doesn’t work alone, but it’s a rate-limiting step. If MTHFR function is compromised, the whole methylation cycle slows.

The C677T variant, present in roughly 40 percent of people of European ancestry, reduces MTHFR enzyme activity by 35 to 70 percent depending on whether you carry one or two copies. That functional deficiency impairs both neurotransmitter synthesis and homocysteine clearance, creating a double hit to cardiovascular autonomy. Your autonomic nervous system can’t regulate heart rate and blood vessel tone as tightly. Homocysteine accumulates, damaging the lining of your blood vessels. Your cells are running slightly depleted energetically.

The result is often poor cardiovascular regulation at rest, an exaggerated heart rate response to standing, brain fog that worsens with exertion, and a general sense that your body can’t quite keep up. You may also have a family history of early heart disease or clotting, though your own cholesterol looks normal.

COMT is the enzyme responsible for clearing dopamine, norepinephrine, and epinephrine from your synapses and bloodstream. These are your stress hormones and your focus chemicals. COMT controls how quickly they are broken down and recycled. This is crucial for moment-to-moment emotional and cardiovascular stability. If COMT clears neurotransmitters too slowly, stress hormones accumulate and keep you in a state of elevated arousal. If it clears them too quickly, you can’t sustain focus or maintain healthy blood pressure.

The Val158Met variant determines COMT activity. About 25 percent of people are homozygous for the slow-clearing Met allele (Met/Met), meaning they metabolize stress hormones at roughly half the normal rate. These individuals accumulate catecholamines in their bloodstream, creating a chronically elevated fight-or-flight state that can mimic or worsen POTS symptoms. Your heart is already in a state of relative overdrive. When you stand, it can’t respond with the fine-tuned adjustment that’s needed.

You experience this as anxiety even in rest, a tendency to feel your heart pounding, extreme sensitivity to caffeine, and a paradoxical state where you’re both exhausted and unable to relax. Stress makes symptoms much worse. You may feel your heart racing in your chest even when lying down, especially at night.

Your heart is an electrical organ. It contracts because of carefully orchestrated electrical signals, and those signals depend on ions, particularly sodium and potassium, flowing in and out of heart muscle cells through ion channels. SCN5A encodes the primary cardiac sodium channel. It allows sodium to flow into heart cells, initiating the electrical impulse that triggers contraction. The timing and duration of this sodium flow determines your heart rate and rhythm. Any disruption in SCN5A function can cause irregular heartbeats or abnormal rate responses.

Variants in SCN5A can range from benign to dangerous. Some reduce sodium channel activity, slowing electrical conduction; others increase it, speeding conduction; still others affect how quickly the channel turns off between beats. Prevalence depends on the specific variant, but rare pathogenic variants in SCN5A are found in roughly 1 to 5 percent of POTS patients. An SCN5A variant can cause your heart to fire action potentials at the wrong rate or rhythm, especially during postural stress when your autonomic nervous system is trying to regulate. Instead of a smooth increase in heart rate, you get erratic, exaggerated responses.

You notice this as sudden heart palpitations when standing, sometimes an irregular or fluttering sensation, or a heart rate that jumps far higher than expected for minimal activity. Lying down brings relief. Exertion or heat can trigger episodes. Some days are fine; others are terrifying.

While SCN5A controls sodium entry into heart cells, KCNQ1 controls potassium exit. Potassium channels are the counterbalance to sodium channels. They allow the heart cell to reset after each contraction, preparing it for the next electrical impulse. KCNQ1 is critical for this repolarization phase. It also plays a role in autonomic nervous system signaling. If KCNQ1 function is impaired, the heart’s electrical cycle gets disrupted. Heart cells don’t reset properly between beats, and the nervous system can’t regulate heart rate smoothly.

Variants in KCNQ1 are less common than SCN5A variants, but they’re clinically significant when present. Some slow potassium channel function, lengthening the time between beats; others affect how the channel opens and closes. A KCNQ1 variant can cause your heart rate to remain elevated longer than it should after standing, or to oscillate instead of settling into a steady pace. The repolarization phase is delayed, creating electrical turbulence that the autonomic nervous system struggles to manage.

You experience this as a heart that won’t calm down after exertion, palpitations that feel chaotic rather than simply fast, or a sensation of your heartbeat being irregular or skipped. Lying down helps, but lying flat for extended periods can sometimes feel uncomfortable because the electrical stress persists.